We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

HORIBA Medical

HORIBA ABX designs, develops and distributes worldwide, in vitro diagnostic systems for biological analysis in medica... read more Featured Products: More products

Download Mobile App





HORIBA Exhibits Compact Benchtop Hematology Analyzers

By LabMedica International staff writers
Posted on 03 Feb 2025
Print article
Image: The Yumizen H550 and H500 are compact benchtop hematology analyzers with enhanced performance (Photo courtesy of HORIBA)
Image: The Yumizen H550 and H500 are compact benchtop hematology analyzers with enhanced performance (Photo courtesy of HORIBA)

HORIBA (Kyoto, Japan) is presenting its latest IVD solutions at Medlab Middle East 2025, including the Yumizen H550 and H500 hematology analyzers.

The HORIBA Medical Segment designs, develops, and distributes worldwide, in vitro diagnostic systems mainly destined for biological analysis in medical laboratories. These automated analyzers meet the needs of various users including patients, doctors, private laboratories, clinics, and university hospitals. HORIBA’s expertise in vitro diagnostics is one of the most respected in hematology worldwide. The new generation of HORIBA’s automated hematology analyzer offers solid and reliable diagnostic technology as well as rapid and consistent results. HORIBA provides a wide range of hematology analyzers and automated instruments to realize blood analysis (blood cell identification and counting) for the diagnosis of various blood-related diseases. These instruments are designed for all kinds of laboratories, from small laboratories (to 150 patients a day), to larger ones (more than 2000 patients a day). These efficient and reliable instruments feature automated racks, data management, and quality tools providing a complete solution for meeting high-quality medical analysis requirements.

The new Yumizen H500 and H550 compact benchtop hematology analyzers featured at Medlab Middle East 2025 deliver enhanced performance, new features, and increased benefits. Both analyzers come with optional infectious flags for malaria and dengue, making them ideal for small labs to meet a variety of clinical lab environments and settings such as routine hematology, satellite labs, oncology care, and blood banks. HORIBA is also highlighting HELO 2.0, an innovative solution covering all the needs of a high throughput automated hematology platform. Flexible and efficient, HELO 2.0 is the optimum answer to the constant evolution of laboratories. Thanks to its data, tube management, waste, blood film, and digitalization management capability, HELO 2.0 not only fulfills all the needs of laboratories but also helps optimize their TAT, floor space, and reagent storage.

Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
New
Gold Member
Chagas Disease Test
CHAGAS Cassette
New
snRNP-C Test
Chorus snRNP-C Test
New
Multi-Channel Pipettor
BioPette Plus

Print article

Channels

Immunology

view channel
Image: Example image of the high-throughput microscopy method used in the study, showing immune cells stained with different fluorescence markers (Photo courtesy of Felix Kartnig/CeMM, MedUni Vienna)

Cutting-Edge Microscopy Technology Enables Tailored Rheumatology Therapies

Rheumatoid arthritis is the most common inflammatory joint disorder, with women three times as likely to suffer from the condition as men. Treatment advances made over the past decades have led to the... Read more

Microbiology

view channel
Image: RNA sequencing directly from whole blood aims to expand access to LRTI testing (Photo courtesy of CARB-X)

Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood

Pneumonia and lower-respiratory-tract infections (LRTIs) are among the top causes of illness and death globally, particularly in vulnerable populations such as the elderly, young children, and immunocompromised... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.